A Study of mDCF in Combination or Not With Atezolizumab in Advanced Squamous Cell Anal Carcinoma
Clinical trial NCT03519295 · COMPLETED
Trial details
- NCT number
- NCT03519295
- Sponsor
- GERCOR - Multidisciplinary Oncology Cooperative Group
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-07-03
- Primary completion
- 2023-02-07
- Enrollment
- 97
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.